Table 4.
NAFLD status overtime | Univariate analysis | Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
No NAFLD | 1 (Reference) | |||||||
Resolved NAFLD | 2.08 (0.95–4.53) | 0.066 | 1.61 (0.73–3.55) | 0.236 | 0.378 (0.14–1.01) | 0.052 | 0.44 (0.16–1.20) | 0.108 |
Incident NAFLD | 2.34 (1.29–4.25) | 0.005 | 2.35 (1.30–4.26) | 0.005 | 2.03 (1.11–3.71) | 0.021 | 2.31 (1.22–4.36) | 0.010 |
Persistent NAFLD | 5.41 (3.57–8.21) | <0.001 | 4.56 (2.99–6.97) | <0.001 | 2.29 (1.33–3.96) | 0.003 | 2.32 (1.30–4.12) | 0.004 |
Model 1: adjusted for age and sex; model 2: adjusted for variables of model 1 and fasting glucose, body mass index, and waist circumference; model 3: adjusted for variables of model 2 and current smoking, hypertension status, baseline alanine transaminase levels, and changes in obesity status. Harrell’s C index; model 1: 0.739 (standard error estimates=0.026), model 2: 0.846 (standard error estimates=0.026), model 3: 0.850 (standard error estimates=0.027).
NAFLD, nonalcoholic fatty liver disease; HR, hazard ratio; CI, confidence interval.